SEATTLE GENETICS INC - COM (SGEN)

CUSIP: 812578102

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Equity / COM
Total 13F shares
126,215,797
Share change
+128,641
Total reported value
$5,034,317,054
Put/Call ratio
98%
Price per share
$39.89
Number of holders
203
Value change
+$5,130,260
Number of buys
5
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 812578102?
CUSIP 812578102 identifies SGEN - SEATTLE GENETICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SEATTLE GENETICS INC - COM (SGEN) as of Q4 2013

As of 31 Dec 2013, SEATTLE GENETICS INC - COM (SGEN) was held by 203 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 126,215,797 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, FMR LLC, BAILLIE GIFFORD & CO, PRIMECAP MANAGEMENT CO/CA/, COLUMBIA WANGER ASSET MANAGEMENT LLC, VANGUARD GROUP INC, CAPITAL GUARDIAN TRUST CO, WELLINGTON MANAGEMENT CO LLP, BlackRock Institutional Trust Company, N.A., and PRICE T ROWE ASSOCIATES INC /MD/. This page lists 203 institutional shareholders reporting positions in this security for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.